Global Radiosurgery and Radiotherapy Robots Market to Reach $7.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Radiosurgery and Radiotherapy Robots estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at aCAGR of 4.6% over the period 2020-2027. X-Ray-Based Robots, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$4.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gamma-Ray-Based Robots segment is readjusted to a revised 3.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 4.3% CAGR
The Radiosurgery and Radiotherapy Robots market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.We bring years of research experience to this 7th edition of our report. The 126-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Accuray, Inc.
- Best Theratronics Ltd.
- BrainLab AG
- Elekta AB
- Huiheng Medical, Inc.
- Masep Medical Science & Technology Development (Shenzhen) Co., Ltd.
- Neusoft Medical Systems Co., Ltd.
- Varian Medical Systems, Inc.
- ViewRay, Inc.